Abstract
There is a gap in the knowledge regarding regulation of local renin–angiotensin system (RAS) in skeletal muscle during development of obesity and insulin resistance in vivo. This study evaluates the obesity- and age-related changes in the expression of local RAS components. Since RAS affects skeletal muscle remodelling, we also evaluated the muscle fibre type composition, defined by myosin heavy chain (MyHC) mRNAs and protein content. Gene expressions were determined by qPCR and/or Western blot analysis in musculus quadriceps of 3- and 8-month-old male obese Zucker rats and their lean controls. The enzymatic activity of aminopeptidase A (APA) was determined flourometrically. Activation of renin receptor (ReR)/promyelocytic leukaemia zinc finger (PLZF) negative feedback mechanism was observed in obesity. The expression of angiotensinogen and AT1 was downregulated by obesity, while neutral endopeptidase and AT2 expressions were upregulated in obese rats with aging. Skeletal muscle APA activity was decreased by obesity, which negatively correlated with the increased plasma APA activity and plasma cholesterol. The expression of angiotensin-converting enzyme (ACE) positively correlated with MyHC mRNAs characteristic for fast-twitch muscle fibres. The obesity- and age-related alterations in the expression of both classical and alternative RAS components suggest an onset of a new equilibrium between ACE/AngII/AT1 and ACE2/Ang1–7/Mas at lower level accompanied by increased renin/ReR/PLZF activation. Increased APA release from the skeletal muscle in obesity might contribute to increased plasma APA activity. There is a link between reduced ACE expression and altered muscle MyHC proportion in obesity and aging.
Similar content being viewed by others
References
Agoudemos MM, Greene AS (2005) Localization of the renin-angiotensin system components to the skeletal muscle microcirculation. Microcirculation 12:627–636. https://doi.org/10.1080/10739680500301664
Arbin V, Claperon N, Fournie-Zaluski MC, Roques BP, Peyroux J (2001) Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat. Br J Pharmacol 133:495–502. https://doi.org/10.1038/sj.bjp.0704098
Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG (2001) Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 281:H2337–H2365
Brink M, Price SR, Chrast J, Bailey JL, Anwar A, Mitch WE, Delafontaine P (2001) Angiotensin II induces skeletal muscle wasting through enhanced protein degradation and down-regulates autocrine insulin-like growth factor I. Endocrinology 142:1489–1496. https://doi.org/10.1210/endo.142.4.8082
Chai W, Wang W, Liu J, Barrett EJ, Carey RM, Cao W, Liu Z (2010) Angiotensin II type 1 and type 2 receptors regulate basal skeletal muscle microvascular volume and glucose use. Hypertension 55:523–530. https://doi.org/10.1161/HYPERTENSIONAHA.109.145409
Cousin C, Bracquart D, Contrepas A, Corvol P, Muller L, Nguyen G (2009) Soluble form of the (pro)renin receptor generated by intracellular cleavage by furin is secreted in plasma. Hypertension 53:1077–1082. https://doi.org/10.1161/HYPERTENSIONAHA.108.127258
Echeverria-Rodriguez O, Del Valle-Mondragon L, Hong E (2014) Angiotensin 1-7 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo. Peptides 51:26–30. https://doi.org/10.1016/j.peptides.2013.10.022
Frisbee JC (2003) Impaired skeletal muscle perfusion in obese Zucker rats. Am J Physiol Regul Integr Comp Physiol 285:R1124–R1134. https://doi.org/10.1152/ajpregu.00239.200300239.2003
Fukushima A, Kinugawa S, Takada S, Matsushima S, Sobirin MA, Ono T, Takahashi M, Suga T, Homma T, Masaki Y, Furihata T, Kadoguchi T, Yokota T, Okita K, Tsutsui H (2014) (Pro)renin receptor in skeletal muscle is involved in the development of insulin resistance associated with postinfarct heart failure in mice. Am J Physiol Endocrinol Metab 307:E503–E514. https://doi.org/10.1152/ajpendo.00449.2013
Graf K, Grafe M, Bossaller C, Niehus J, Schulz KD, Auch-Schwelk W, Fleck E (1993) Degradation of bradykinin by neutral endopeptidase (EC 3.4.24.11) in cultured human endothelial cells. Eur J Clin Chem Clin Biochem 31:267–272
Gross DN, Farmer SR, Pilch PF (2004) Glut4 storage vesicles without Glut4: transcriptional regulation of insulin-dependent vesicular traffic. Mol Cell Biol 24:7151–7162. https://doi.org/10.1128/MCB.24.16.7151-7162
Haugaard SB, Vaag A, Hoy CE, Madsbad S (2007) Desaturation of skeletal muscle structural and depot lipids in obese individuals during a very-low-calorie diet intervention. Obesity (Silver Spring) 15:117–125. https://doi.org/10.1038/oby.2007.508
Healy DP, Wilk S (1993) Localization of immunoreactive glutamyl aminopeptidase in rat brain. II. Distribution and correlation with angiotensin II. Brain Res 606:295–303
Henriksen EJ, Prasannarong M (2013) The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle. Mol Cell Endocrinol 378:15–22. https://doi.org/10.1016/j.mce.2012.04.011
Johnson PR, Stern JS, Horwitz BA, Harris RE Jr, Greene SF (1997) Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia. Am J Clin Nutr 66:890–903. https://doi.org/10.1093/ajcn/66.4.890
Johnston AP, Baker J, De Lisio M, Parise G (2011) Skeletal muscle myoblasts possess a stretch-responsive local angiotensin signalling system. J Renin-Angiotensin-Aldosterone Syst 12:75–84. https://doi.org/10.1177/1470320310381795
Kemp BA, Bell JF, Rottkamp DM, Howell NL, Shao W, Navar LG, Padia SH, Carey RM (2012) Intrarenal angiotensin III is the predominant agonist for proximal tubule angiotensin type 2 receptors. Hypertension 60:387–395. https://doi.org/10.1161/HYPERTENSIONAHA.112.191403
King PA, Horton ED, Hirshman MF, Horton ES (1992) Insulin resistance in obese Zucker rat (fa/fa) skeletal muscle is associated with a failure of glucose transporter translocation. J Clin Invest 90:1568–1575. https://doi.org/10.1172/JCI116025
Krskova K, Filipcik P, Zilka N, Olszanecki R, Korbut R, Gajdosechova L, Zorad S (2011) Angiotensinogen and angiotensin-converting enzyme mRNA decrease and AT1 receptor mRNA and protein increase in epididymal fat tissue accompany age-induced elevation of adiposity and reductions in expression of GLUT4 and peroxisome proliferator-activated receptor (PPARgamma). J Physiol Pharmacol 62:403–410
Malendowicz SL, Ennezat PV, Testa M, Murray L, Sonnenblick EH, Evans T, LeJemtel TH (2000) Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure. Circulation 102:2210–2213
Mathe D (1995) Dyslipidemia and diabetes: animal models. Diabetes Metab 21:106–111
McBride TA (2006) AT1 receptors are necessary for eccentric training-induced hypertrophy and strength gains in rat skeletal muscle. Exp Physiol 91:413–421. https://doi.org/10.1113/expphysiol.2005.032490
Morais RL, Hilzendeger AM, Visniauskas B, Todiras M, Alenina N, Mori MA, Araujo RC, Nakaie CR, Chagas JR, Carmona AK, Bader M, Pesquero JB (2017) High aminopeptidase A activity contributes to blood pressure control in ob/ob mice by AT2 receptor-dependent mechanism. Am J Physiol Heart Circ Physiol 312:H437–H445. https://doi.org/10.1152/ajpheart.00485.2016
Nagatsu I, Nagatsu T, Yamamoto T, Glenner GG, Mehl JW (1970) Purification of aminopeptidase A in human serum and degradation of angiotensin II by the purified enzyme. Biochim Biophys Acta 198:255–270
Nilwik R, Snijders T, Leenders M, Groen BB, van Kranenburg J, Verdijk LB, van Loon LJ (2013) The decline in skeletal muscle mass with aging is mainly attributed to a reduction in type II muscle fiber size. Exp Gerontol 48:492–498. https://doi.org/10.1016/j.exger.2013.02.012
Phillips MI, Speakman EA, Kimura B (1993) Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43:1–20
Pinterova L, Krizanova O, Zorad S (2000) Rat epididymal fat tissue express all components of the renin-angiotensin system. Gen Physiol Biophys 19:329–334
Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A (1993) Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev 45:87–146
Rubio-Ruiz ME, Del Valle-Mondragon L, Castrejon-Tellez V, Carreon-Torres E, Diaz-Diaz E, Guarner-Lans V (2014) Angiotensin II and 1-7 during aging in metabolic syndrome rats. Expression of AT1, AT2 and Mas receptors in abdominal white adipose tissue. Peptides 57:101–108. https://doi.org/10.1016/j.peptides.2014.04.021
Sabuhi R, Ali Q, Asghar M, Al-Zamily NR, Hussain T (2011) Role of the angiotensin II AT2 receptor in inflammation and oxidative stress: opposing effects in lean and obese Zucker rats. Am J Physiol Renal Physiol 300:F700–F706. https://doi.org/10.1152/ajprenal.00616.2010
Schefe JH, Menk M, Reinemund J, Effertz K, Hobbs RM, Pandolfi PP, Ruiz P, Unger T, Funke-Kaiser H (2006) A novel signal transduction cascade involving direct physical interaction of the renin/prorenin receptor with the transcription factor promyelocytic zinc finger protein. Circ Res 99:1355–1366. https://doi.org/10.1161/01.RES.0000251700.00994.0d
Schonke M, Bjornholm M, Chibalin AV, Zierath JR, Deshmukh AS (2018) Proteomics analysis of skeletal muscle from leptin-deficient Ob/Ob mice reveals adaptive remodeling of metabolic characteristics and fiber type composition. Proteomics 18. https://doi.org/10.1002/pmic.201700375
Schweda F, Friis U, Wagner C, Skott O, Kurtz A (2007) Renin release. Physiology (Bethesda) 22:310–319. https://doi.org/10.1152/physiol.00024.2007
Wang Y, Pessin JE (2013) Mechanisms for fiber-type specificity of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care 16:243–250. https://doi.org/10.1097/MCO.0b013e328360272d
Wong V, Szeto L, Uffelman K, Fantus IG, Lewis GF (2006) Enhancement of muscle glucose uptake by the vasopeptidase inhibitor, omapatrilat, is independent of insulin signaling and the AMP kinase pathway. J Endocrinol 190:441–450. https://doi.org/10.1677/joe.1.06396
Yoshikawa A, Aizaki Y, Kusano K, Kishi F, Susumu T, Iida S, Ishiura S, Nishimura S, Shichiri M, Senbonmatsu T (2011) The (pro)renin receptor is cleaved by ADAM19 in the Golgi leading to its secretion into extracellular space. Hypertens Res 34:599–605. https://doi.org/10.1038/hr.2010.284
Zhang B, Tanaka H, Shono N, Miura S, Kiyonaga A, Shindo M, Saku K (2003) The I allele of the angiotensin-converting enzyme gene is associated with an increased percentage of slow-twitch type I fibers in human skeletal muscle. Clin Genet 63:139–144
Zurmanova J, Soukup T (2013) Comparison of myosin heavy chain mRNAs, protein isoforms and fiber type proportions in the rat slow and fast muscles. Physiol Res 62:445–453
Funding
This study was supported by grants VEGA 2/0174/14 and APVV grants 15-0229 and 15-0565.
Author information
Authors and Affiliations
Contributions
V.L. prepared major parts of the manuscript. V.L. and L.B. carried out western blots analyses, measurements of enzyme activity, conducted real-time PCR analyses and data interpretation. M. S. and L.B. conducted glucose tolerance tests and biochemical analyses. L.H. carried out transcardial perfusion surgery. L.B., K.K. and S.Z. supervised and edited the manuscript. R. O. and S.Z. planned and organized the study and contributed to the revisions and the final drafts of the manuscript. All authors have read and approved the final manuscript.
Corresponding author
Ethics declarations
Experimental procedures involving animals were approved by the Jagiellonian University Ethical Committee on Animal Experiments.
Conflict of interest
The authors declare that there is no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(DOCX 373 kb)
Rights and permissions
About this article
Cite this article
Lóry, V., Balážová, L., Kršková, K. et al. Obesity and aging affects skeletal muscle renin–angiotensin system and myosin heavy chain proportions in pre-diabetic Zucker rats. J Physiol Biochem 75, 351–365 (2019). https://doi.org/10.1007/s13105-019-00689-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13105-019-00689-1